Skip to search formSkip to main contentSkip to account menu

gadobutrol

Known as: (10-((1RS,2SR)-2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium, gadobutrol [Chemical/Ingredient], gadolinium(III) 2,2',2''-(10-((2R,3S )-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
A gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI). Gadobutrol is a non-ionic… 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (2)

Contrast MediaOrganometallic Compounds
GADOBUTROL 604.72 mg in 1 mL INTRAVENOUS INJECTION [Gadavist]Gadolinium-based Contrast Agent [EPC]

Narrower (1)

Gadovist

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Intraindividual Quantitative and Qualitative Comparison of Gadopentetate Dimeglumine and Gadobutrol in Time-Resolved Contrast-Enhanced 4-Dimensional Magnetic Resonance Angiography in Minipigs
ObjectivesThe concentration and relaxivities of contrast agents affect quantitative and qualitative image quality in contrast… 
2013
2013
Dynamic Contrast Enhanced MRI of the Prostate: Comparison of Gadobutrol and Gd-DTPA
Abstract Purpose: To evaluate the enhancement profile of the macrocyclic contrast medium (CM) gadobutrol in comparison to linear… 
2009
2009
Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentetate Dimeglumine-Enhanced Magnetic Resonance Imaging in Five Hundred Seventy-Two Patients With Known or Suspected Liver Lesions: Results of a…
Objective:To evaluate the diagnostic efficacy (accuracy, sensitivity, specificity) of 1.0 M gadobutrol versus 0.5 M gadopentetate… 
2008
2008
Comparison of different contrast agents and doses for quantitative MR myocardial perfusion imaging
To investigate three different contrast agents at different injection volumes for repetitive quantitative multislice myocardial… 
2005
2005
Comparison of 0.5‐M Gd‐DTPA with 1.0‐M gadobutrol for magnetic resonance angiography of the supplying arteries of the spinal cord in thoracoabdominal aortic aneurysm patients
To prospectively compare 0.5‐M gadopentetate dimeglumine (Gd‐DTPA) with 1.0‐M gadobutrol for contrast‐enhanced magnetic resonance… 
2004
2004
In Vivo Measurement of Gadolinium Concentration in a Rat Glioma Model by Monochromatic Quantitative Computed Tomography: Comparison Between Gadopentetate Dimeglumine and Gadobutrol
Rationale and Objectives:Monochromatic quantitative computed tomography allows a nondestructive and quantitative measurement of… 
Highly Cited
2003
Highly Cited
2003
Using a 1 M Gd‐chelate (gadobutrol) for total‐body three‐dimensional MR angiography: Preliminary experience
To determine whether higher concentrated gadolinium chelates are advantageous for the recently introduced concept of total‐body… 
1997
1997
Sicherheit und Nutzen von Gadobutrol bei Patienten mit zerebralen Tumoren (Phase-III-Studie)
Ziel: Methodik: Ergebnisse: Schlußfolgerung: Purpose: Methods: Results: Conclusion: 
1995
1995
Evaluation of Gadobutrol in a Rabbit Model as a New Lanthanide Contrast Agent for Computed Tomography
RATIONALE AND OBJECTIVES.The efficacy of the neutral lanthanide contrast agent gadobutrol was compared to that of the iodinated… 
Highly Cited
1994
Highly Cited
1994
Dynamic contrast‐enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium‐DTPA‐polylysine, and gadolinium‐DTPA‐cascade‐polymer
The enhancement properties of gadobutrol (40 and 80 μmol/kg body weight, 550 daltons), gadolinium‐DTPA‐polylysine (20 μmol/kg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)